Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Following earlier compounds such as Semaglutide and Tirzepatide, Retatrutide expanded receptor coverage through simultaneous GLP-1, GIP, and glucagon receptor activity
The STEP trials demonstrated average weight loss of 14.9% of body weight at 68 weeks with the 2.4mg weekly dose
Tirzepatide gives you a powerful metabolic boost while our wellness team supports you with nutrition, behavior coaching, and lifestyle guidance
317: 160910 Lauterburg BH, Corcoran GB, Mitchell JR
Importantly, tirzepatide is not indicated for the treatment of type 1 diabetes or diabetic ketoacidosis
GLP-1RAs have revolutionized the treatment of metabolic disorders, particularly type 2 diabetes and obesity
US$ 27.33
US$ 23.57
US$ 26.72
US$ 25.41
US$ 23.54
US$ 23.67
